Lawrence Long

4.4k total citations
119 papers, 3.0k citations indexed

About

Lawrence Long is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Lawrence Long has authored 119 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Infectious Diseases, 45 papers in Epidemiology and 33 papers in Virology. Recurrent topics in Lawrence Long's work include HIV/AIDS Research and Interventions (87 papers), HIV Research and Treatment (33 papers) and HIV/AIDS drug development and treatment (32 papers). Lawrence Long is often cited by papers focused on HIV/AIDS Research and Interventions (87 papers), HIV Research and Treatment (33 papers) and HIV/AIDS drug development and treatment (32 papers). Lawrence Long collaborates with scholars based in United States, South Africa and Netherlands. Lawrence Long's co-authors include Matthew P. Fox, Sydney Rosen, Ian Sanne, Alana T. Brennan, Mhairi Maskew, Kathryn Schnippel, Bruce A. Larson, Denise Evans, Gesine Meyer‐Rath and Constance Mongwenyana and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Lawrence Long

116 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lawrence Long United States	30	2.4k	1.2k	846	557	414	119	3.0k
Didier Koumavi Ekouévi France	39	3.6k 1.5×	2.0k 1.7×	1.6k 1.9×	1.1k 2.0×	569 1.4×	237	5.1k
Manhattan Charurat United States	28	2.6k 1.1×	1.4k 1.2×	1.0k 1.2×	856 1.5×	250 0.6×	110	3.5k
Damalie Nakanjako Uganda	25	1.1k 0.4×	670 0.6×	509 0.6×	398 0.7×	281 0.7×	108	2.1k
Charles van der Horst United States	29	2.3k 1.0×	2.0k 1.7×	725 0.9×	329 0.6×	249 0.6×	79	3.7k
Eve Lackritz United States	31	1.5k 0.6×	1.7k 1.4×	725 0.9×	524 0.9×	1.4k 3.3×	55	4.8k
Kusum Nathoo Zimbabwe	31	2.1k 0.9×	1.5k 1.2×	635 0.8×	708 1.3×	442 1.1×	114	3.5k
Catherine Orrell South Africa	36	4.4k 1.8×	1.9k 1.5×	1.9k 2.3×	1.1k 2.0×	502 1.2×	159	4.9k
Xavier Anglaret France	35	3.6k 1.5×	2.0k 1.6×	1.6k 1.9×	382 0.7×	345 0.8×	141	4.3k
Gilles Wandeler Switzerland	28	2.0k 0.8×	1.8k 1.5×	656 0.8×	522 0.9×	326 0.8×	139	3.1k
Allan W. Taylor United States	20	2.5k 1.1×	2.1k 1.7×	645 0.8×	1.0k 1.8×	222 0.5×	37	3.2k

Countries citing papers authored by Lawrence Long

Since Specialization

Citations

This map shows the geographic impact of Lawrence Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Long more than expected).

Fields of papers citing papers by Lawrence Long

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Long. The network helps show where Lawrence Long may publish in the future.

Co-authorship network of co-authors of Lawrence Long

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Long. A scholar is included among the top collaborators of Lawrence Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Long. Lawrence Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Long, Lawrence, Brooke E Nichols, Gesine Meyer‐Rath, et al.. (2025). Sputum and Tongue Swab Molecular Testing for the In-Home Diagnosis of Tuberculosis in Unselected Household Contacts: A Cost and Cost-Effectiveness Analysis. Clinical Infectious Diseases. 82(1). 49–57. 1 indexed citations

Govathson, Caroline, Lawrence Long, Mark N. Lurie, et al.. (2024). “Emotional stress is more detrimental than the virus itself”: A qualitative study to understand HIV testing and pre‐exposure prophylaxis (PrEP) use among internal migrant men in South Africa. Journal of the International AIDS Society. 27(3). e26225–e26225. 3 indexed citations

Dovel, Kathryn, Kelvin Balakasi, Julie Hubbard, et al.. (2023). Identifying efficient linkage strategies for men (IDEaL): a study protocol for an individually randomised control trial. BMJ Open. 13(7). e070896–e070896. 6 indexed citations

Kakuhikire, Bernard, Caroline Govathson, Lawrence Long, et al.. (2022). Men missing from the HIV care continuum in sub‐Saharan Africa: a meta‐analysis and meta‐synthesis. Journal of the International AIDS Society. 25(3). e25889–e25889. 30 indexed citations

Jo, Youngji, Lise Jamieson, Ijeoma Edoka, et al.. (2021). Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa. Open Forum Infectious Diseases. 8(3). ofab040–ofab040. 33 indexed citations

Long, Lawrence, et al.. (2021). Getting resources to those who need them: the evidence we need to budget for underserved populations in sub‐Saharan Africa. Journal of the International AIDS Society. 24(S3). e25707–e25707. 2 indexed citations

Bor, Jacob, Cornelius Nattey, Elisabet Lönnermark, et al.. (2021). Perceived barriers to the uptake of health services among first-year university students in Johannesburg, South Africa. PLoS ONE. 16(1). e0245427–e0245427. 10 indexed citations

Mokhele, Idah, et al.. (2021). Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa. BMC Pregnancy and Childbirth. 21(1). 453–453. 12 indexed citations

Larson, Bruce A., et al.. (2020). Understanding the costs and the cost structure of a community-based HIV and gender-based violence (GBV) prevention program: the Woza Asibonisane Community Responses Program in South Africa. BMC Health Services Research. 20(1). 526–526.

10.

Feeley, Alison, et al.. (2019). Dietary intake among paediatric HIV-positive patients initiating antiretroviral therapy in Johannesburg, South Africa. Vulnerable Children and Youth Studies. 15(2). 155–170. 5 indexed citations

11.

Berry, Kaitlyn M., Carly A. Rodriguez, Rebecca Berhanu, et al.. (2019). Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa. BMC Public Health. 19(1). 973–973. 25 indexed citations

12.

Meyer‐Rath, Gesine, Leigh F. Johnson, Yogan Pillay, et al.. (2017). Changing the South African national antiretroviral therapy guidelines: The role of cost modelling. PLoS ONE. 12(10). e0186557–e0186557. 48 indexed citations

13.

Shearer, Kate, Kate Clouse, Gesine Meyer‐Rath, et al.. (2017). Citizenship status and engagement in HIV care: an observational cohort study to assess the association between reporting a national ID number and retention in public-sector HIV care in Johannesburg, South Africa. BMJ Open. 7(1). e013908–e013908. 4 indexed citations

14.

Onoya, Dorina, Cornelius Nattey, Mhairi Maskew, et al.. (2017). Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa. AIDS Patient Care and STDs. 31(5). 205–212. 25 indexed citations

15.

Rosen, Sydney, Mhairi Maskew, Matthew P. Fox, et al.. (2016). Initiating Antiretroviral Therapy for HIV at a Patient’s First Clinic Visit: The RapIT Randomized Controlled Trial. PLoS Medicine. 13(5). e1002015–e1002015. 229 indexed citations

16.

Rohr, Julia K., Prudence Ive, C. Robert Horsburgh, et al.. (2016). Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa. PLoS ONE. 11(8). e0161469–e0161469. 29 indexed citations

17.

Evans, Denise, et al.. (2016). Can Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa. AIDS and Behavior. 20(11). 2717–2728. 16 indexed citations

18.

Fox, Matthew P., Mhairi Maskew, A. P. MacPhail, et al.. (2012). Cohort Profile: The Themba Lethu Clinical Cohort, Johannesburg, South Africa. International Journal of Epidemiology. 42(2). 430–439. 77 indexed citations

19.

Schnippel, Kathryn, Gesine Meyer‐Rath, Lawrence Long, et al.. (2012). Scaling up Xpert MTB/RIF technology: the costs of laboratory‐ vs. clinic‐based roll‐out in South Africa. Tropical Medicine & International Health. 17(9). 1142–1151. 46 indexed citations

20.

Long, Lawrence, Matthew P. Fox, Ian Sanne, & Sydney Rosen. (2010). The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa. AIDS. 24(6). 915–919. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact